Business
DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in digital health solutions for chronic condition management, today announced that its Board of Directors has initiated a comprehensive strategic review to maximize shareholder value following multiple unsolicited inbound strategic inquiries from interested parties.
About this update from Dariohealth Corp.
[{"type":"text","content":"Board forms Special Committee and engages Perella Weinberg Partners as financial advisor","length":88,"tagName":"p","attribs":{}},{"type":"text","content":"Company completed an oversubscribed $17.5 million private placement to capitalize on significant commercial momentum ","length":116,"tagName":"p","attribs":{}},{"type":"text","content":"Dario optimized its cap table by converting preferred shares into common shares and common shares equivalents, positioning it for future opportunities","length":150,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, Sept. 25, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in digital health solutions for chronic condition management, today announced that its Board of Directors has initiated a comprehensive strategic review to maximize shareholder value following multiple unsolicited inbound strategic inquiries from interested parties.","length":412,"tagName":"p"},{"type":"image","alt":"DarioHealth Corp. Logo","displaySize":"","headline":null,"caption":"DarioHealth Corp. Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":351,"url":"https://media.zenfs.com/en/prnewswire.com/94f92c69e0c652a14c6d6b0558ca89e9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/t9cXiK9gWjUz8mMvXeUAmw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTYxOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/94f92c69e0c652a14c6d6b0558ca89e9","width":400,"height":351}}},{"type":"text","content":"Dario's Board of Directors has established a special committee (the "Special Committee") of independent directors and engaged Perella Weinberg Partners, a leading global independent advisory firm, as financial advisor.","length":232,"tagName":"p"},{"type":"text","content":"The Special Committee will consider a full range of potential opportunities including a sale, merger, strategic business combination, or continued execution of the Company's successful standalone strategy.","length":209,"tagName":"p"},{"type":"text","content":"Recent Company Developments:","length":28,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Optimized Cap Table: The Company recently completed the conversion of outstanding preferred shares into shares of common stock (and common stock equivalents...